539 related articles for article (PubMed ID: 34512627)
1. Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation.
Fujiwara H
Front Immunol; 2021; 12():703298. PubMed ID: 34512627
[TBL] [Abstract][Full Text] [Related]
2. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
Kumari R; Palaniyandi S; Hildebrandt GC
Dig Dis Sci; 2019 Mar; 64(3):669-677. PubMed ID: 30523482
[TBL] [Abstract][Full Text] [Related]
3. Microbiome and diversity indices during blood stem cells transplantation - new perspectives?
Parco S; Benericetti G; Vascotto F; Palmisciano G
Cent Eur J Public Health; 2019 Dec; 27(4):335-339. PubMed ID: 31951695
[TBL] [Abstract][Full Text] [Related]
4. Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD.
Köhler N; Zeiser R
Front Immunol; 2018; 9():3179. PubMed ID: 30705680
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation.
Shono Y; van den Brink MRM
Nat Rev Cancer; 2018 May; 18(5):283-295. PubMed ID: 29449660
[TBL] [Abstract][Full Text] [Related]
6. Intestinal microbiota-related effects on graft-versus-host disease.
Shono Y; Docampo MD; Peled JU; Perobelli SM; Jenq RR
Int J Hematol; 2015 May; 101(5):428-37. PubMed ID: 25812838
[TBL] [Abstract][Full Text] [Related]
7. The role of microbiota in allogeneic hematopoietic stem cell transplantation.
Chang CC; Hayase E; Jenq RR
Expert Opin Biol Ther; 2021 Aug; 21(8):1121-1131. PubMed ID: 33412949
[TBL] [Abstract][Full Text] [Related]
8. Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease.
Mohamed FA; Thangavelu G; Rhee SY; Sage PT; O'Connor RS; Rathmell JC; Blazar BR
Front Immunol; 2021; 12():757836. PubMed ID: 34712243
[TBL] [Abstract][Full Text] [Related]
9. Acute Graft-versus-Host Disease: Novel Biological Insights.
Teshima T; Reddy P; Zeiser R
Biol Blood Marrow Transplant; 2016 Jan; 22(1):11-6. PubMed ID: 26453971
[TBL] [Abstract][Full Text] [Related]
10. Microbiome-intestine cross talk during acute graft-versus-host disease.
Rafei H; Jenq RR
Blood; 2020 Jul; 136(4):401-409. PubMed ID: 32526029
[TBL] [Abstract][Full Text] [Related]
11. Specific gut microbiome members are associated with distinct immune markers in pediatric allogeneic hematopoietic stem cell transplantation.
Ingham AC; Kielsen K; Cilieborg MS; Lund O; Holmes S; Aarestrup FM; Müller KG; Pamp SJ
Microbiome; 2019 Sep; 7(1):131. PubMed ID: 31519210
[TBL] [Abstract][Full Text] [Related]
12. The emerging roles of the gut microbiome in allogeneic hematopoietic stem cell transplantation.
Khuat LT; Dave M; Murphy WJ
Gut Microbes; 2021; 13(1):1966262. PubMed ID: 34455917
[TBL] [Abstract][Full Text] [Related]
13. A Promising Insight: The Potential Influence and Therapeutic Value of the Gut Microbiota in GI GVHD.
Li J; Zhang X; Chen Y; Zheng Q; Zhao M; Jiang H
Oxid Med Cell Longev; 2022; 2022():2124627. PubMed ID: 35571252
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic-mediated modification of the intestinal microbiome in allogeneic hematopoietic stem cell transplantation.
Whangbo J; Ritz J; Bhatt A
Bone Marrow Transplant; 2017 Feb; 52(2):183-190. PubMed ID: 27526283
[TBL] [Abstract][Full Text] [Related]
15. Short chain fatty acids: Postbiotics/metabolites and graft versus host disease colitis.
Riwes M; Reddy P
Semin Hematol; 2020 Jan; 57(1):1-6. PubMed ID: 32690138
[TBL] [Abstract][Full Text] [Related]
16. Dental Biofilm Microbiota Dysbiosis Is Associated With the Risk of Acute Graft-
Heidrich V; Bruno JS; Knebel FH; de Molla VC; Miranda-Silva W; Asprino PF; Tucunduva L; Rocha V; Novis Y; Arrais-Rodrigues C; Fregnani ER; Camargo AA
Front Immunol; 2021; 12():692225. PubMed ID: 34220852
[TBL] [Abstract][Full Text] [Related]
17. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota, microbiota-derived metabolites, and graft-versus-host disease.
Yue X; Zhou H; Wang S; Chen X; Xiao H
Cancer Med; 2024 Feb; 13(3):e6799. PubMed ID: 38239049
[TBL] [Abstract][Full Text] [Related]
19. The role of the intestinal microbiota in allogeneic HCT: clinical associations and preclinical mechanisms.
Nguyen CL; Docampo MD; van den Brink MR; Markey KA
Curr Opin Genet Dev; 2021 Feb; 66():25-35. PubMed ID: 33388483
[TBL] [Abstract][Full Text] [Related]
20. T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor.
Jiang H; Fu D; Bidgoli A; Paczesny S
Front Immunol; 2021; 12():761448. PubMed ID: 34675938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
